Skip to main content
. 2020 Oct 20;21(20):7767. doi: 10.3390/ijms21207767

Table A5.

Patient #5 laboratory findings.

Pt#5 ESR mm/h IS CRP mg/L WBC/μL HB g/dL PLT/μL IgG mg/dL IgA mg/dL
Before JAKinhibs 56 3.4 46.6 11,030 12.3 216,000 1870 162
After JAKinhibs 81 2.0 16.0 7650 10.3 362,000 1323 185
Last FUP 69 4.0 11.6 5750 11.3 507,000 1334 172